| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PNTD.0005774 |
| P8608 | Fatcat ID | release_tix3ra57tbc6rcnbjby7vw3fri |
| P932 | PMC publication ID | 5529023 |
| P698 | PubMed publication ID | 28708893 |
| P50 | author | Alireza Badirzadeh | Q56001271 |
| Yasaman Taslimi | Q88979769 | ||
| Maryam Heidari-Kharaji | Q104515210 | ||
| Elham Gholami | Q114409960 | ||
| Tahereh Taheri | Q39615644 | ||
| Sima Rafati | Q39615689 | ||
| P2093 | author name string | Maryam Niyyati | |
| Zahra Abdossamadi | |||
| Baharehsadat Sedaghat | |||
| P2860 | cites work | Leishmaniasis worldwide and global estimates of its incidence | Q21134611 |
| DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| Basic local alignment search tool | Q25938991 | ||
| MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods | Q27860929 | ||
| Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis | Q28475723 | ||
| Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis | Q28486287 | ||
| Recent developments in the MAFFT multiple sequence alignment program | Q29547333 | ||
| Genomic organisation and transcription characterisation of the gene encoding Leishmania (Leishmania) amazonensis arginase and its protein structure prediction. | Q30330440 | ||
| Roles of conserved residues in the arginase family | Q30429868 | ||
| Age-related alteration of arginase activity impacts on severity of leishmaniasis | Q33334323 | ||
| Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis | Q33566856 | ||
| Epidemiological analysis of Leishmania tropica strains and giemsa-stained smears from Syrian and Turkish leishmaniasis patients using multilocus microsatellite typing (MLMT). | Q33596783 | ||
| Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis | Q33608744 | ||
| Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator | Q33619062 | ||
| Leishmania amazonensis arginase compartmentalization in the glycosome is important for parasite infectivity | Q34221938 | ||
| Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia | Q34312411 | ||
| Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection | Q34563619 | ||
| The immunology of susceptibility and resistance to Leishmania major in mice | Q34988360 | ||
| Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species | Q35740567 | ||
| Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica. | Q35836338 | ||
| Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka | Q35933255 | ||
| In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite. | Q36050879 | ||
| Risk Mapping and Situational Analysis of Cutaneous Leishmaniasis in an Endemic Area of Central Iran: A GIS-Based Survey | Q36116622 | ||
| Enhanced survival of Leishmania major in neutrophil granulocytes in the presence of apoptotic cells. | Q36276999 | ||
| Multiplex PCR as a tool for the diagnosis of Leishmania spp. kDNA and the gapdh housekeeping gene of mammal hosts | Q36310698 | ||
| Evolutionary conservation of a microbody targeting signal that targets proteins to peroxisomes, glyoxysomes, and glycosomes | Q36530215 | ||
| Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy | Q36768985 | ||
| L-arginine metabolism and its impact on host immunity against Leishmania infection | Q37015574 | ||
| Evaluation of nitric oxide production and proliferation activity of recombinant Bacterioferritin of Helicobacter pylori on macrophages. | Q51540271 | ||
| IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. | Q52689151 | ||
| Factors influencing Leishmania major infection in IL-4-deficient BALB/c mice. | Q53909788 | ||
| Resistance toLeishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages | Q54284360 | ||
| Trypanosoma spp., Leishmania spp. and Leptomonas spp.: Enzymes of ornithine-arginine metabolism | Q58861027 | ||
| Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity | Q59274608 | ||
| Determination of arginase activity in macrophages: a micromethod | Q72182280 | ||
| Nitric oxide biosynthesis by Leishmania amazonensis promastigotes containing a high percentage of metacyclic forms | Q83022089 | ||
| Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion. | Q37080079 | ||
| Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major | Q37116125 | ||
| Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes | Q37546985 | ||
| Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002-2011: a case series | Q37726490 | ||
| Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis | Q37950217 | ||
| Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages | Q38266887 | ||
| Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process. | Q38275289 | ||
| Arginase: an old enzyme with new tricks | Q38452432 | ||
| Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection. | Q38600399 | ||
| Optimization of the Timing of Induction for the Assessment of Nitric Oxide Production in Leishmania major Infected Macrophage Cells | Q38719216 | ||
| Role of oxidative stress and apoptosis in the cellular response of murine macrophages upon Leishmania infection | Q39317576 | ||
| Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model | Q40663539 | ||
| Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice | Q41858732 | ||
| Arginase I induction during Leishmania major infection mediates the development of disease | Q42005264 | ||
| Recognition of a peroxisomal tripeptide entry signal by the glycosomes of Trypanosoma brucei | Q42086020 | ||
| The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages | Q42944402 | ||
| Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants | Q44801422 | ||
| A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection | Q45409151 | ||
| Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. | Q46423511 | ||
| Biochemical and biophysical properties of a highly active recombinant arginase from Leishmania (Leishmania) amazonensis and subcellular localization of native enzyme | Q46654493 | ||
| Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation | Q46723195 | ||
| An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis | Q46868571 | ||
| Nitric oxide synthase (NOS) characterization in Leishmania amazonensis axenic amastigotes. | Q46972845 | ||
| Phylogeny of related functions: the case of polyamine biosynthetic enzymes | Q47664357 | ||
| Comparative analysis of the nitric oxide production by Leishmania sp. | Q47802740 | ||
| Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae | Q48059220 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0005774 | |
| P577 | publication date | 2017-07-14 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites | |
| P478 | volume | 11 |
| Q51147614 | Amino Acids As Mediators of Metabolic Cross Talk between Host and Pathogen. |
| Q46332681 | Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis. |
| Q45324427 | Case Report: First Coinfection Report of Mixed Leishmania infantum/Leishmania major and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Iran. |
| Q50114687 | Characteristics of inflammatory reactions during development of liver abscess in hamsters inoculated with Entamoeba nuttalli. |
| Q61796921 | DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica |
| Q49931152 | First case report of atypical disseminated cutaneous leishmaniasis in an opium abuser in Iran. |
| Q47775690 | Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice |
| Q55043523 | Leishmania Hijacks Myeloid Cells for Immune Escape. |
| Q90682219 | Leishmania Spp-Host Interaction: There Is Always an Onset, but Is There an End? |
| Q50070363 | Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice. |
| Q92635722 | Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape |
| Q92888016 | Promastigote secretory gel from natural and unnatural sand fly vectors exacerbate Leishmania major and Leishmania tropica cutaneous leishmaniasis in mice |
| Q54242711 | The Uptake and Metabolism of Amino Acids, and Their Unique Role in the Biology of Pathogenic Trypanosomatids. |
| Q58718800 | Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin |
| Q53685684 | Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages? |
Search more.